November Research Group Opens Pharmacovigilance Center of Excellence in Noida, India

Share Article

November Research Group, LLC., announces the opening of their Pharmacovigilance (PV) Center of Excellence, in Noida, India.

Our team of consultants is highly experienced in Oracle Argus Safety and possesses deep knowledge in all aspects of drug safety and pharmacovigilance.

November Research Group, LLC. (http://www.novemberresearch.com), announced the opening of their Pharmacovigilance (PV) Center of Excellence, in Noida, India. Seth Warhaftig, President of November Research, said of the grand opening, “As part of the November Research global growth strategy, November Research continues to strive for excellent cross-industry experience in drug safety and pharmacovigilance. Our team of consultants is highly experienced in Oracle Argus Safety and possesses deep knowledge in all aspects of drug safety and pharmacovigilance.”

As part of the planned global investment, services will include Oracle Argus Safety scoping/strategy, implementation, upgrades, migrations and post implementation support. The Noida office will also support November Research’s streamlined data capture system, PRIMO, and will also allow for full global support for their clients.

November Research will also continue to enhance their services and support around the world, including client expansion in Japan, Europe and the US in 2012.

About November Research Group

November Research Group is a professional services firm that provides a complete spectrum of software and services to the pharmacovigilance departments in the biopharmaceutical industry, with extensive expertise in: implementation and support for the Oracle Argus Safety Suite, Oracle AERS, and other commercial adverse event reporting systems; requirements specification and system selection; custom software application and tool development, and software validation. In addition, November Research Group provides the PRIMO application for companies to enable a streamlined and rapid data intake for adverse event cases from all sources.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Susan A. Jalbert
Visit website